148 related articles for article (PubMed ID: 15854787)
1. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder.
Soloff PH; Meltzer CC; Becker C; Greer PJ; Constantine D
Psychiatry Res; 2005 Apr; 138(3):183-95. PubMed ID: 15854787
[TBL] [Abstract][Full Text] [Related]
2. A fenfluramine-activated FDG-PET study of borderline personality disorder.
Soloff PH; Meltzer CC; Greer PJ; Constantine D; Kelly TM
Biol Psychiatry; 2000 Mar; 47(6):540-7. PubMed ID: 10715360
[TBL] [Abstract][Full Text] [Related]
3. Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder.
Lange C; Kracht L; Herholz K; Sachsse U; Irle E
Psychiatry Res; 2005 Jul; 139(2):115-26. PubMed ID: 15978784
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.
Oquendo MA; Krunic A; Parsey RV; Milak M; Malone KM; Anderson A; van Heertum RL; John Mann J
Neuropsychopharmacology; 2005 Jun; 30(6):1163-72. PubMed ID: 15770239
[TBL] [Abstract][Full Text] [Related]
5. Impulsivity and prefrontal hypometabolism in borderline personality disorder.
Soloff PH; Meltzer CC; Becker C; Greer PJ; Kelly TM; Constantine D
Psychiatry Res; 2003 Jul; 123(3):153-63. PubMed ID: 12928103
[TBL] [Abstract][Full Text] [Related]
6. 5HT2A receptor binding is increased in borderline personality disorder.
Soloff PH; Price JC; Meltzer CC; Fabio A; Frank GK; Kaye WH
Biol Psychiatry; 2007 Sep; 62(6):580-7. PubMed ID: 17448449
[TBL] [Abstract][Full Text] [Related]
7. Fronto-limbic dysfunction in borderline personality disorder: a 18F-FDG positron emission tomography study.
Salavert J; Gasol M; Vieta E; Cervantes A; Trampal C; Gispert JD
J Affect Disord; 2011 Jun; 131(1-3):260-7. PubMed ID: 21272937
[TBL] [Abstract][Full Text] [Related]
8. Amygdala-prefrontal disconnection in borderline personality disorder.
New AS; Hazlett EA; Buchsbaum MS; Goodman M; Mitelman SA; Newmark R; Trisdorfer R; Haznedar MM; Koenigsberg HW; Flory J; Siever LJ
Neuropsychopharmacology; 2007 Jul; 32(7):1629-40. PubMed ID: 17203018
[TBL] [Abstract][Full Text] [Related]
9. Processing of autobiographical memory retrieval cues in borderline personality disorder.
Schnell K; Dietrich T; Schnitker R; Daumann J; Herpertz SC
J Affect Disord; 2007 Jan; 97(1-3):253-9. PubMed ID: 16837057
[TBL] [Abstract][Full Text] [Related]
10. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography.
Siever LJ; Buchsbaum MS; New AS; Spiegel-Cohen J; Wei T; Hazlett EA; Sevin E; Nunn M; Mitropoulou V
Neuropsychopharmacology; 1999 May; 20(5):413-23. PubMed ID: 10192822
[TBL] [Abstract][Full Text] [Related]
11. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder.
Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ
Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356
[TBL] [Abstract][Full Text] [Related]
12. Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.
Soloff PH; Chiappetta L; Mason NS; Becker C; Price JC
Psychiatry Res; 2014 Jun; 222(3):140-8. PubMed ID: 24751216
[TBL] [Abstract][Full Text] [Related]
13. Abnormal prefrontal cortical response during affective processing in borderline personality disorder.
Ruocco AC; Medaglia JD; Ayaz H; Chute DL
Psychiatry Res; 2010 May; 182(2):117-22. PubMed ID: 20417064
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.
Herting B; Beuthien-Baumann B; Pöttrich K; Donix M; Triemer A; Lampe JB; von Kummer R; Herholz K; Reichmann H; Holthoff VA
Mov Disord; 2007 Mar; 22(4):490-7. PubMed ID: 17260333
[TBL] [Abstract][Full Text] [Related]
15. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
[TBL] [Abstract][Full Text] [Related]
16. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.
Mann JJ; Malone KM; Diehl DJ; Perel J; Cooper TB; Mintun MA
Am J Psychiatry; 1996 Feb; 153(2):174-82. PubMed ID: 8561196
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.
Mann JJ; Malone KM; Diehl DJ; Perel J; Nichols TE; Mintun MA
J Cereb Blood Flow Metab; 1996 May; 16(3):418-26. PubMed ID: 8621746
[TBL] [Abstract][Full Text] [Related]
18. Reduced anterior and posterior cingulate gray matter in borderline personality disorder.
Hazlett EA; New AS; Newmark R; Haznedar MM; Lo JN; Speiser LJ; Chen AD; Mitropoulou V; Minzenberg M; Siever LJ; Buchsbaum MS
Biol Psychiatry; 2005 Oct; 58(8):614-23. PubMed ID: 15993861
[TBL] [Abstract][Full Text] [Related]
19. Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder.
New AS; Hazlett EA; Newmark RE; Zhang J; Triebwasser J; Meyerson D; Lazarus S; Trisdorfer R; Goldstein KE; Goodman M; Koenigsberg HW; Flory JD; Siever LJ; Buchsbaum MS
Biol Psychiatry; 2009 Dec; 66(12):1107-14. PubMed ID: 19748078
[TBL] [Abstract][Full Text] [Related]
20. Neural correlates of impulsive responding in borderline personality disorder: ERP evidence for reduced action monitoring.
de Bruijn ER; Grootens KP; Verkes RJ; Buchholz V; Hummelen JW; Hulstijn W
J Psychiatr Res; 2006 Aug; 40(5):428-37. PubMed ID: 16257009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
